22
DAFTAR PUSTAKA
Aslam, S., Santha, T., Leone A., & Wicox, C, 2006, Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis., Kidney International (2006) 70, 2109–2115. doi:10.1038/sj.ki.5001983
Bakris,GL., 2001, A practical approach to achieving recommended BP goals in diabetic patients. Arch Intern Med 161:2662‐2667
Benowitz, N.L., 2001, Obat Antihipertensi, dalam Katzung, B.G., Farmakologi Dasar dan Klinik, diterjemahkan oleh Staf dosen Farmakologi Fakultas Kedokteran Universitas Sriwijaya, Ed. VI, 269-270, EGC, Jakarta.
Chobanian, A.V.,Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jones, D.W., Materson, B.J., Oparil, S., & Wright, J.T., 2004, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:The Complete Report,U.S Department of Health and Human Services, New York.
Cipolle, R.J., Strand, L.M., & Morley, P.C., 1998, Pharmaceutical Care Practice, 59, 75, 82-83, 88-90, 114-115, The McGraw-Hill Companies,New York.
DeBellis, R. J., Smith, B. S., Cawley, P. A., & Burniske, G. M, 2000, Drug Dosing in Critically Ill Patients with Renal Failure: A Pharmacokinetic Approach, University of Maryland Medical Center, Baltimore.
Dipiro, J. T., Talbert, L. R., Yee, G. C., Matzke, G. R., Wells, B. G., & Posey, L. M., 2008, Pharmacotherapy A Pathophysiologic Approach Seventh Edition, The McGraw-Hill Companies, Inc, United States of America.
Dussol, B. MD, PhD., Frances, J.M. MD., Morange, S. MD., Delpero, C. S. MD, PhD., Mundler, O. MD., & Berland, Y. MD ., 2012, A Pilot Study Comparing Furosemide and Hydrochlorothiazide in Patients With Hypertension and Stage 4 or 5 Chronic Kidney Disease, The Journal of Clinical Hypertension Vol 14 | No 1 | January 2012. The American Society of Hypertension, INC.
23
Hidayati, T., 2007. Tesis: Hubungan hipertensi minuman suplemen energi dan merokok dengan kejadian penyakit ginjal kronik yang menjalani Hemodialisis di RSU PKU Muhammadiyah Yogyakarta. Universitas Gadjah Mada, Yogyakarta.
Karyadi, E., 2002, Hidup Bersama Penyakit Hipertensi, Asam Urat, Jantung Koroner, Intisari Mediatama, Jakarta.
Katzung, Bertram G., 2004, Farmakologi Dasar dan Klinik, diterjemahkan oleh Bagian Farmakologi Fakultas Kedokteran Universitas Airlangga, Ed. I, 495, Salemba Empat, Jakarta.
Kestenbaum, B., Gillen, D. L., Sherrard, D. J., Seliger, S., Ball, A., & Breen, C.S, 2002, Calcium Channel Blocker Use and Mortality Among Patients with End-Stage Renal Disease, Kidney International, Vol 61 (2002), pp. 2157-2164
Levey, S. A., Coresh, J., Bolton, K., Culleton, B., Harvey, S. K., & Kusek, J. 2002. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease, The National Kidney Foundation, New York.
Mulyani, Y., 2005, Evaluasi Penggunaan Obat pada Penderita Gangguan Fungsi Ginjal, Usia lanjut, Hipertensi dan Diabetes Mellitus di bagian Ilmu Penyakit Dalam Perjan Rumah Sakit Hasan Sadikin Bandung, Abstrak, (online), (http://digilib.itb.ac.id/gdl.php?mod=browse&op=read&id=, diakses 25 Agustus 2011).
Murdiana, H. E. 2007. Tesis :Evaluasi penggunaan obat antihipertensi pada pasien Diabetes Mellitus tipe 2 di rawat jalan RS Dr. Muwardi Surakarta. Universitas Gadjah Mada, Yogyakarta
Mutschler, E., 1991, Dinamika Obat, di terjemahkan oleh Mathilda B. Widianto dan Anna setiadi Ranti, Edisi ke-5, 487, Penerbit ITB, Bandung.
Nugroho, K. Heri., 2003, Laporan Karya Akhir : Hubungan Status Volume dan Tekanan Darah Penderita Hemodialisis Kronik RS Dr. Kariadi Semarang. Fakultas Kedokteran UNDIP, Semarang.
Price, S.A., & Lorraine M.W., 2005, Patofisiologi: Konsep Klinis Proses-proses Penyakit, diterjemahkan oleh Brahm U. Pendit, Huriawati H., Pita W., dewi Asih M., Edisi 6, 582-583, EGC, Jakarta.
Rahajeng, E., 2009, Masalah Hipertensi di Indonesia,
24
Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm,L.L., Klag, M.J, Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D.J., McCullough,P.A., Kasiske, B.L., Kelepouris, E., & Wilson , P.W., 2003 Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention (online)(http://circ.ahajournals.org/cgi/content/full/108/17/215, diakses 27 Desember 2011).
Saseen, J. J., & Maclaughlin, E. J., 2008, Cardiovascular Disorder : Hypertension, Editor : Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., Posey, L. M., Pharmacotherapy A Pathophysiological Approach, Sixth Edition, MC GRAWHILL Medical Publishing Division, New York.
Setiawardani, B., 2007, Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Geriatri Rawat Inap di RSUD Dr. Sardjito Periode Januari-Desember 2006,Skripsi, F-MIPA Universitas Islam Indonesia, Yogyakarta.
Siauw, S.L, 1994, Tekanan Darah Tinggi atau Hipertensi, PT. Dabara Bengawan, Solo
Sidabutar, R. P., & Wiguno, P., 1998, Ilmu Penyakit Dalam, Jilid II, balai Penerbit FKUI, Jakarta.
Skolnik, N. S,M.D., Beck, J.D, M.D., & Clark, M. M.D.,2000. Combination Antihypertensive Drugs: Recommendations for Use, Am Fam Physician. 2000 May 15;61(10):3049-3056. Abington Memorial Hospital, Jenkintown, Pennsylvania
Suyono & Lyswanti, E.N., 2008, Studi Penggunaan Obat Antihipertensi Pada Penderita Hipertensi Rawat Inap : Penelitian di RSU Dr. Saiful Anwar Malang, (online), (http://www.adln.lib.unair.ac.id/go.php?id=gdlhub-gd-s12006suyonoeren1669&PHPSESSID=4a5098ca21600bae878e3cbe5a83 116, diakses tanggal 27 Desember 2011).
Vasavada, N., Saha, C., & Agarwl, R, 2003, A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.Kidney International, Vol. 64 (2003), pp. 632–640. Indiana University School of Medicine, Indianapolis
25
